BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients

被引:27
作者
Berastegui, Cristina [1 ]
Gomez-Olles, Susana [1 ,2 ]
Sanchez-Vidaurre, Sara [1 ]
Culebras, Mario [1 ]
Monforte, Victor [1 ,2 ]
Lopez-Meseguer, Manuel [1 ]
Bravo, Carlos [1 ,2 ]
Ramon, Maria-Antonia [1 ]
Romero, Laura [3 ]
Sole, Joan [3 ]
Cruz, Maria-Jesus [1 ,2 ]
Roman, Antonio [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Pneumol, Barcelona, Spain
[2] Ciber Enfermedades Resp Ciberes, Barcelona, Spain
[3] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Cirurg Torac, Barcelona, Spain
关键词
BOS; bronchoalveolar lavage; chronic rejection; cytokines; RAS; BRONCHIOLITIS-OBLITERANS-SYNDROME; BRONCHOALVEOLAR LAVAGE; COMPUTED-TOMOGRAPHY; SYNDROME RAS; REJECTION; HEART; EXPRESSION; THERAPY; TH1; AZITHROMYCIN;
D O I
10.1111/ctr.12898
中图分类号
R61 [外科手术学];
学科分类号
摘要
The long-term success of lung transplantation (LT) is limited by chronic lung allograft dysfunction (CLAD). Different phenotypes of CLAD have been described, such as bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). The purpose of this study was to investigate the levels of cytokines and chemokines in bronchoalveolar lavage fluid (BALF) as markers of these CLAD phenotypes. BALF was collected from 51 recipients who underwent (bilateral and unilateral) LT. The study population was divided into three groups: stable (ST), BOS, and RAS. Levels of interleukin (IL)-4, IL-5, IL-6, IL-10, IL-13, tumor necrosis factor alpha (TNF-), interferon-gamma (IFN-), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were measured using the multiplex technology. BALF neutrophilia medians were higher in BOS (38%) and RAS (30%) than in ST (8%) (P=.008; P=.012). Regarding BALF cytokines, BOS and RAS patients showed higher levels of INF- than ST (P=.02; P=.008). Only IL-5 presented significant differences between BOS and RAS (P=.001). BALF neutrophilia is as a marker for both CLAD phenotypes, BOS and RAS, and IL-5 seems to be a potential biomarker for the RAS phenotype.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Chronic lung allograft dysfunction phenotypes and treatment
    Verleden, Stijn E.
    Vos, Robin
    Vanaudenaerde, Bart M.
    Verleden, Geert M.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2650 - 2659
  • [2] Survival Determinants in Lung Transplant Patients With Chronic Allograft Dysfunction
    Verleden, Geert M.
    Vos, Robin
    Verleden, Stijn E.
    De Wever, Walter
    De Vleeschauwer, Stephanie I.
    Willems-Widyastuti, Anna
    Scheers, Hans
    Dupont, Lieven J.
    Van Raemdonck, Dirk E.
    Vanaudenaerde, Bart M.
    TRANSPLANTATION, 2011, 92 (06) : 703 - 708
  • [3] Phenotyping Established Chronic Lung Allograft Dysfunction Predicts Extracorporeal Photopheresis Response in Lung Transplant Patients
    Greer, M.
    Dierich, M.
    De Wall, C.
    Suhling, H.
    Rademacher, J.
    Welte, T.
    Haverich, A.
    Warnecke, G.
    Ivanyi, P.
    Buchholz, S.
    Gottlieb, J.
    Fuehner, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (04) : 911 - 918
  • [4] A new classification system for chronic lung allograft dysfunction
    Verleden, Geert M.
    Raghu, Ganesh
    Meyer, Keith C.
    Glanville, Allan R.
    Corris, Paul
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (02) : 127 - 133
  • [5] Adaptive and innate immune responses in a rat orthotopic lung transplant model of chronic lung allograft dysfunction
    Evers, Alena
    Atanasova, Srebrena
    Fuchs-Moll, Gabriele
    Petri, Kathrin
    Wilker, Sigrid
    Zakrzewicz, Anna
    Hirschburger, Markus
    Padberg, Winfried
    Grau, Veronika
    TRANSPLANT INTERNATIONAL, 2015, 28 (01) : 95 - 107
  • [6] CT at onset of chronic lung allograft dysfunction in lung transplant patients predicts development of the restrictive phenotype and survival
    Dettmer, Sabine
    Shin, Hoen-Oh
    Vogel-Claussen, Jens
    Westphal, Max
    Haverich, Axel
    Warnecke, Gregor
    Welte, Tobias
    Wacker, Frank
    Gottlieb, Jens
    Suhling, Hendrik
    EUROPEAN JOURNAL OF RADIOLOGY, 2017, 94 : 78 - 84
  • [7] Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres
    Trindade, Anil J.
    Thaniyavarn, Tany
    Townsend, Keri
    Klasek, Robin
    Tsveybel, Karen P.
    Kennedy, John C.
    Goldberg, Hilary J.
    El-Chemaly, Souheil
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation
    Suwara, Monika I.
    Vanaudenaerde, Bart M.
    Verleden, Stijn E.
    Vos, Robin
    Green, Nicola J.
    Ward, Chris
    Borthwick, Lee A.
    Vandermeulen, Elly
    Lordan, Jim
    Van Raemdonck, Dirk E.
    Corris, Paul A.
    Verleden, Geert M.
    Fisher, Andrew J.
    TRANSPLANT INTERNATIONAL, 2014, 27 (08) : 857 - 867
  • [9] Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients
    DerHovanessian, Ariss
    Todd, Jamie L.
    Zhang, Alice
    Li, Ning
    Mayalall, Aradhna
    Copeland, C. Ashley Finlen
    Shino, Michael
    Pavlisko, Elizabeth N.
    Wallace, W. Dean
    Gregson, Aric
    Ross, David J.
    Saggar, Rajan
    Lynch, Joseph P., III
    Belperio, John
    Snyder, Laurie D.
    Palmer, Scott M.
    Weigt, S. Sam
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (05) : 627 - 635
  • [10] Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation
    Suwara, Monika I.
    Vanaudenaerde, Bart M.
    Verleden, Stijn E.
    Borthwick, Lee A.
    Vos, Robin
    Green, Nicola J.
    Ward, Chris
    Van Raemdonck, Dirk E.
    Corris, Paul A.
    Mann, Derek A.
    Verleden, Geert M.
    Fisher, Andrew J.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40